Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality: Observational Study of Primary Care Patients in England
Published version of a preprint
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the associations between age at type 2 diabetes diagnosis and the relative and absolute risk of all-cause and cause-specific mortality in England. RESEARCH DESIGN AND METHODS: In this cohort study using primary care data from the Clinical Practice Research Datalink, we identified 108,061 individuals with newly diagnosed type 2 diabetes (16–50 years of age), matched to 829,946 individuals without type 2 diabetes. We estimated all-cause and cause-specific mortality (cancer, cardiorenal, other [noncancer or cardiorenal]) by age at diagnosis, using competing-risk survival analyses adjusted for key confounders. RESULTS: Comparing individuals with versus without type 2 diabetes, the relative risk of death decreased with an older age at diagnosis: the hazard ratio for all-cause mortality was 4.32 (95% CI 3.35–5.58) in individuals diagnosed at ages 16–27 years compared with 1.53 (95% CI 1.46–1.60) at ages 48–50 years. Smaller relative risks by increasing age at diagnosis were also observed for cancer, cardiorenal, and noncancer or cardiorenal death. Irrespective of age at diagnosis, the 10-year absolute risk of all-cause and cause-specific mortality were higher in individuals with type 2 diabetes; yet, the absolute differences were small. CONCLUSIONS: Although the relative risk of death in individuals with versus without type 2 was higher at younger ages, the 10-year absolute risk of all investigated causes of death was small and similar in the two groups. Further multidecade studies could help estimate the long-term risk of complications and death in individuals with early-onset type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This culminates in a greater risk of microvascular and macrovascular outcomes in people with EOT2D compared to later‐onset disease and increased risk of mortality. 2 , 8”
From Designing a regional clinical service for people with early‐onset type 2 diabetes in England (2025) · cites this paper as [2]
In the citing paper
“EOT2D has a distinct phenotype from later‐onset T2D, with an increased risk of complications 2”
From Designing a regional clinical service for people with early‐onset type 2 diabetes in England (2025) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Sattar, N., Lee, M. M. Y., Kristensen, S. L., Branch, K. R. H., Del Prato, S., Khurmi, N. S., Lam, C. S. P., Lopes, R. D., McMurray, J. J. V., Pratley, R. E., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00203-5 · Cited by 1,599
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
Wolf, A., Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., & Myles, P. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz034 · Cited by 861
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0334-z · Cited by 483
Self-citationPearson-Stuttard, J., Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., & Gregg, E. W. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30431-9 · Cited by 335
Self-citationKuan, V., Denaxas, S., Gonzalez-Izquierdo, A., Direk, K., Bhatti, O., Husain, S., Sutaria, S., Hingorani, M., Nitsch, D., Parisinos, C. A., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30012-3 · Cited by 305
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70137-8 · Cited by 296
Self-citation
Research works printed but not linked: 21
- IDF Diabetes Atlas 2021 . 10th ed. 2021. Available from https://diabetesatlas.org/atlas/tenth-edition/?dlmodal=active&dlsrc=https%3A%2F%2Fdiabetesatlas.org%2Fidfawp%2Fresource-files%2F2021%2F07%2FIDF_Atlas_10th_Edition_2021.pdf. Accessed 18 July 2023
- Nanayakkara, 2021, Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses, Diabetologia, 64, 275, 10.1007/s00125-020-05319-w · DOI · Paper page
- Barker, 2022, Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: a pooled analysis, World J Diabetes, 13, 260, 10.4239/wjd.v13.i3.260 · DOI · Paper page
- Al-Saeed, 2016, An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes, Diabetes Care, 39, 823, 10.2337/dc15-0991 · DOI · Paper page
- Barnett, 2010, A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with type 2 diabetes in Tayside, Scotland, Diabet Med, 27, 1124, 10.1111/j.1464-5491.2010.03075.x · DOI · Paper page
- Zhao, 2021, Associations of type 2 diabetes onset age with cardiovascular disease and mortality: the Kailuan Study, Diabetes Care, 44, 1426, 10.2337/dc20-2375 · DOI · Paper page
- Spiegelhalter, 2017, Risk and uncertainty communication, Annu Rev Stat Appl, 4, 31, 10.1146/annurev-statistics-010814-020148 · DOI · Paper page
- Lambert, 2009, Further development of flexible parametric models for survival analysis, Stata J, 9, 265, 10.1177/1536867X0900900206 · DOI · Paper page
- Huo, 2018, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011, Diabetologia, 61, 1055, 10.1007/s00125-018-4544-z · DOI · Paper page
- Chan, 2014, Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis, Am J Med, 127, 616, 10.1016/j.amjmed.2014.03.018 · DOI · Paper page
- Ling, 2023, All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: a comparative, trend analysis in Canada, Spain, and the UK, Diabetes Obes Metab, 25, 132, 10.1111/dom.14856 · DOI
- Ke, 2019, Excess burden of mental illness and hospitalization in young-onset type 2 diabetes, Ann Intern Med, 171, 78, 10.7326/L19-0243 · DOI
- Barker, 2023, Age at diagnosis of type 2 diabetes and depression, diabetes-related distress and self-compassion, Diabetes Care, 46, 579, 10.2337/dc22-1237 · DOI · Paper page
- Wu, 2021, Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study, Diabetologia, 64, 1990, 10.1007/s00125-021-05494-4 · DOI
- Morton, 2022, The association of attained age, age at diagnosis, and duration of type 2 diabetes with the long-term risk for major diabetes-related complications, Diabetes Res Clin Pract, 190, 110022, 10.1016/j.diabres.2022.110022 · DOI
- Ye, 2023, Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study, J Clin Endocrinol Metab, 108, 1202, 10.1210/clinem/dgac658 · DOI
- Campbell, 2009, Effects of pay for performance on the quality of primary care in England, N Engl J Med, 361, 368, 10.1056/NEJMsa0807651 · DOI · Paper page
- de Lusignan, 2015, An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR), J Innov Health Inform, 22, 255, 10.14236/jhi.v22i2.79 · DOI
- Persson, 2020, CPRD Aurum database: assessment of data quality and completeness of three important comorbidities, Pharmacoepidemiol Drug Saf, 29, 1456, 10.1002/pds.5135 · DOI
- Greifer, 2022, Matching methods for confounder adjustment: an addition to the epidemiologist’s toolbox, Epidemiol Rev, 43, 118, 10.1093/epirev/mxab003 · DOI
- Stolpe, 2021, Decline of coronary heart disease mortality is strongly effected by changing patterns of underlying causes of death: an analysis of mortality data from 27 countries of the WHO European region 2000 and 2013, Eur J Epidemiol, 36, 57, 10.1007/s10654-020-00699-0 · DOI
Cited by
Designing a regional clinical service for people with early‐onset type 2 diabetes in England
Goldney, J., Alabraba, V., Sarkar, P., Morgan, H., Hamza, M., Skarlatos, M., Slater, T., Sargeant, J. A., O'Callaghan, R., Hadjiconstantinou, M., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.15479 · Cited by 7
Self-citation
Metadata
- Authors
- Barker, M. M., Davies, M. J., Sargeant, J. A., Chan, J. C. N., Gregg, E. W., Shabnam, S., Khunti, K., & Zaccardi, F.
- Affiliations
- 1Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, U.K.
- 3Diabetes Research Centre, University of Leicester, College of Life Sciences, Leicester General Hospital, Leicester, U.K.
- 6Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
- 7School of Population Health, Royal College of Surgeons of Ireland, University of Medicine and Health Sciences, Dublin, Ireland
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2023-08-25
- Volume
- 46
- Issue
- 11
- Pages
- 1965-1972
- ISSN
- 0149-5992
- 1935-5548
- Cited by
- 26
- References
- 11
- Language
- en
- Funders
- NIHR Leicester Biomedical Research Centre
- National Institute for Health and Care Research (NIHR201165)
- NIHR Applied Research Collaboration East Midlands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.